CPRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $10,380,983.30

Catalyst Pharmaceuticals Insider Trading History Chart

Catalyst Pharmaceuticals Share Price & Price History

^$23.92

▼ -0.33 (-1.36%)

As of 04/1/2025 05:00 PM ET

Days: 30 | 90 | 365

Catalyst Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2025	Gary Ingenito	Insider	Sell	44,904	$22.09	$991,929.36	68,873
3/3/2025	Brian Elsbernd	Insider	Sell	62,975	$22.98	$1,447,165.50	188,564
12/10/2024	Steve Miller	Insider	Sell	50,000	$21.93	$1,096,500.00	686,996
11/27/2024	Gary Ingenito	Insider	Sell	12,000	$22.72	$272,640.00	51,391
11/27/2024	Molly Harper	Director	Sell	17,500	$22.00	$385,000.00
8/21/2024	David S. Tierney	Director	Sell	15,000	$20.10	$301,500.00	348,874
8/20/2024	Steve Miller	Insider	Sell	150,000	$20.35	$3,052,500.00	675,124
8/9/2024	Jeffrey Del Carmen	Insider	Sell	36,058	$18.42	$664,188.36	12,369
6/7/2024	Jeffrey Del Carmen	Insider	Sell	7,541	$16.07	$121,183.87	18,427
6/5/2024	Gary Ingenito	Insider	Sell	80,000	$16.16	$1,292,800.00	51,391
6/4/2024	Richard J. Daly	CEO	Sell	17,323	$15.97	$276,648.31	234,824
6/3/2024	Molly Harper	Director	Sell	5,333	$16.30	$86,927.90
4/8/2024	David S. Tierney	Director	Sell	25,000	$15.68	$392,000.00	348,874
3/27/2024	Brian Elsbernd	Insider	Sell	25,000	$16.44	$411,000.00	124,433
12/12/2023	David S. Tierney	Director	Sell	50,000	$13.32	$666,000.00	333,541
12/11/2023	Alicia Grande	CFO	Sell	60,000	$13.76	$825,600.00	50,557
12/8/2023	Alicia Grande	CFO	Sell	40,000	$14.28	$571,200.00	50,557
12/5/2023	Steve Miller	Insider	Sell	40,000	$14.24	$569,600.00	647,457
5/15/2023	Patrick J. McEnany	CEO	Sell	26,151	$13.23	$345,977.73	3,945,436
4/5/2023	David S. Tierney	Director	Sell	30,000	$16.83	$504,900.00	313,541
3/29/2023	Jeffrey Del Carmen	Insider	Sell	40,000	$16.70	$668,000.00	7,541
3/28/2023	Alicia Grande	CFO	Sell	58,216	$16.54	$962,892.64	50,557
3/22/2023	Alicia Grande	CFO	Sell	41,784	$16.50	$689,436.00	50,557
3/20/2023	Brian Elsbernd	Insider	Sell	50,000	$16.07	$803,500.00	138,076
12/6/2022	Gary Ingenito	Insider	Sell	5,918	$16.85	$99,718.30	30,802
11/23/2022	Philip H. Coelho	Director	Sell	9,999	$17.45	$174,482.55	149,553
11/23/2022	Steve Miller	COO	Sell	20,000	$17.34	$346,800.00	553,791
11/22/2022	Alicia Grande	CFO	Sell	120,000	$16.53	$1,983,600.00	27,442
11/21/2022	Patrick J. McEnany	CEO	Sell	150,000	$15.33	$2,299,500.00	3,902,606
11/21/2022	Philip H. Coelho	Director	Sell	70,000	$15.23	$1,066,100.00	179,553
11/21/2022	Steve Miller	COO	Sell	80,000	$15.28	$1,222,400.00	573,791
11/18/2022	Patrick J. McEnany	CEO	Sell	350,000	$15.62	$5,467,000.00	3,902,606
11/15/2022	Alicia Grande	CFO	Sell	60,000	$15.77	$946,200.00	147,442
11/11/2022	Donald A. Denkhaus	Director	Sell	20,000	$16.59	$331,800.00	277,666
11/11/2022	Preethi Sundaram	insider	Sell	56,786	$16.38	$930,154.68
9/23/2022	Alicia Grande	CFO	Sell	60,000	$11.90	$714,000.00	207,442
9/16/2022	Alicia Grande	CFO	Sell	90,000	$13.50	$1,215,000.00	267,442
9/15/2022	Preethi Sundaram	insider	Sell	18,214	$14.49	$263,920.86	22,053
9/14/2022	Alicia Grande	CFO	Sell	50,000	$15.57	$778,500.00	357,442
9/14/2022	Donald A. Denkhaus	Director	Sell	20,000	$15.34	$306,800.00	297,666
9/13/2022	Patrick J. McEnany	CEO	Sell	80,765	$15.33	$1,238,127.45	4,849,452
9/13/2022	Steve Miller	COO	Sell	107,933	$16.90	$1,824,067.70	653,791
8/29/2022	Alicia Grande	CFO	Sell	57,000	$14.20	$809,400.00	407,442
8/26/2022	Alicia Grande	CFO	Sell	11,095	$14.40	$159,768.00	464,442
8/22/2022	David S. Tierney	Director	Sell	20,000	$14.16	$283,200.00	308,207
8/18/2022	Steve Miller	COO	Sell	150,000	$13.53	$2,029,500.00	761,724
8/17/2022	Alicia Grande	CFO	Sell	130,741	$13.86	$1,812,070.26	475,537
6/22/2022	Gary Ingenito	Insider	Sell	6,152	$6.61	$40,664.72	22,053

See Full Table

SEC Filings (Institutional Ownership Changes) for Catalyst Pharmaceuticals (NASDAQ:CPRX)

79.22% of Catalyst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Catalyst Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	51,550	$1.08M	0.0%	-13.5%	0.042%
3/18/2025	California State Teachers Retirement System	100,230	$2.09M	0.0%	-0.7%	0.083%
3/17/2025	Wealth Enhancement Advisory Services LLC	21,419	$0.45M	0.0%	+7.0%	0.018%
3/12/2025	Centaurus Financial Inc.	7,740	$0.16M	0.0%	-18.8%	0.006%
2/28/2025	Park Square Financial Group LLC	1,379	$29K	0.0%	N/A	0.001%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	178,850	$3.73M	0.0%	N/A	0.150%
2/25/2025	Armis Advisers LLC	14,669	$0.31M	0.0%	N/A	0.012%
2/20/2025	Mackenzie Financial Corp	34,531	$0.72M	0.0%	+132.9%	0.029%
2/20/2025	Castlekeep Investment Advisors LLC	85,059	$1.78M	0.3%	N/A	0.071%
2/18/2025	Neo Ivy Capital Management	35,652	$0.74M	0.1%	N/A	0.030%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	263,905	$5.51M	0.0%	+11.7%	0.221%
2/17/2025	Voloridge Investment Management LLC	531,836	$11.10M	0.0%	-30.7%	0.446%
2/17/2025	Woodline Partners LP	252,969	$5.28M	0.0%	-17.5%	0.212%
2/17/2025	Squarepoint Ops LLC	111,705	$2.33M	0.0%	+38.1%	0.094%
2/17/2025	Tidal Investments LLC	38,141	$0.80M	0.0%	-4.8%	0.032%
2/17/2025	Teza Capital Management LLC	20,917	$0.44M	0.1%	N/A	0.018%
2/17/2025	State of Wyoming	25,418	$0.53M	0.1%	+9.5%	0.021%
2/17/2025	Tema Etfs LLC	11,352	$0.24M	0.1%	N/A	0.010%
2/17/2025	Sherbrooke Park Advisers LLC	14,785	$0.31M	0.1%	-7.1%	0.012%
2/17/2025	Rafferty Asset Management LLC	117,092	$2.44M	0.0%	-4.4%	0.098%
2/17/2025	ProShare Advisors LLC	33,699	$0.70M	0.0%	+44.5%	0.028%
2/17/2025	Man Group plc	315,817	$6.59M	0.0%	+24.0%	0.265%
2/17/2025	Nuveen Asset Management LLC	1,304,391	$27.22M	0.0%	+14.5%	1.094%
2/17/2025	Millennium Management LLC	520,778	$10.87M	0.0%	-7.0%	0.437%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	68,252	$1.43M	0.0%	+3.4%	0.057%
2/17/2025	Lazard Asset Management LLC	125,343	$2.61M	0.0%	+58.6%	0.105%
2/17/2025	Integral Health Asset Management LLC	300,000	$6.26M	0.5%	-25.0%	0.252%
2/17/2025	Jacobs Levy Equity Management Inc.	912,999	$19.05M	0.1%	-13.7%	0.765%
2/17/2025	Janus Henderson Group PLC	476,023	$9.94M	0.0%	+32.2%	0.399%
2/17/2025	Gotham Asset Management LLC	38,953	$0.81M	0.0%	+7.8%	0.033%
2/17/2025	Graham Capital Management L.P.	24,905	$0.52M	0.0%	-27.2%	0.021%
2/17/2025	Clark Capital Management Group Inc.	207,733	$4.34M	0.0%	N/A	0.174%
2/17/2025	D. E. Shaw & Co. Inc.	18,173	$0.38M	0.0%	N/A	0.015%
2/17/2025	Deutsche Bank AG	200,395	$4.18M	0.0%	-65.3%	0.168%
2/17/2025	Deerfield Management Company L.P. Series C	3,133,011	$65.39M	1.2%	-49.7%	2.627%
2/17/2025	EP Wealth Advisors LLC	10,531	$0.22M	0.0%	N/A	0.009%
2/17/2025	CoreCap Advisors LLC	35,880	$0.75M	0.0%	+8,870.0%	0.030%
2/17/2025	Cetera Investment Advisers	43,114	$0.90M	0.0%	+35.2%	0.036%
2/17/2025	BOKF NA	24,548	$0.54M	0.0%	-12.9%	0.021%
2/17/2025	Brevan Howard Capital Management LP	12,817	$0.27M	0.0%	-36.1%	0.011%
2/17/2025	Capstone Investment Advisors LLC	16,173	$0.34M	0.0%	-54.6%	0.014%
2/17/2025	Castlekeep Investment Advisors LLC	1,796,552	$37.49M	0.2%	N/A	1.506%
2/17/2025	Bank of America Corp DE	1,568,791	$32.74M	0.0%	+139.5%	1.315%
2/17/2025	BNP Paribas Financial Markets	127,679	$2.67M	0.0%	-16.7%	0.107%
2/17/2025	Ameriprise Financial Inc.	282,834	$5.90M	0.0%	+1.9%	0.237%
2/17/2025	Algert Global LLC	47,920	$1M	0.0%	+185.2%	0.040%
2/14/2025	Jane Street Group LLC	37,251	$0.78M	0.0%	-90.7%	0.031%
2/14/2025	PDT Partners LLC	20,664	$0.43M	0.0%	+5.2%	0.017%
2/14/2025	Schonfeld Strategic Advisors LLC	72,980	$1.52M	0.0%	N/A	0.061%
2/14/2025	AQR Capital Management LLC	477,011	$9.96M	0.0%	+3.8%	0.400%
2/14/2025	Lido Advisors LLC	24,658	$0.52M	0.0%	+12.0%	0.021%
2/14/2025	Northern Trust Corp	1,503,566	$31.38M	0.0%	+8.7%	1.261%
2/14/2025	The Manufacturers Life Insurance Company	60,366	$1.26M	0.0%	-2.3%	0.051%
2/14/2025	Tudor Investment Corp ET AL	59,552	$1.24M	0.0%	N/A	0.050%
2/14/2025	Quarry LP	5,000	$0.10M	0.0%	N/A	0.004%
2/14/2025	Aquatic Capital Management LLC	29,261	$0.61M	0.0%	-38.1%	0.025%
2/14/2025	Boothbay Fund Management LLC	76,865	$1.60M	0.0%	-27.6%	0.064%
2/14/2025	New Vernon Capital Holdings II LLC	5,822	$0.12M	0.1%	N/A	0.005%
2/14/2025	Oberweis Asset Management Inc.	467,100	$9.75M	0.5%	+1.9%	0.392%
2/14/2025	Hancock Whitney Corp	38,322	$0.80M	0.0%	-1.6%	0.032%
2/14/2025	Voya Investment Management LLC	52,416	$1.09M	0.0%	+24.9%	0.044%
2/14/2025	Price T Rowe Associates Inc. MD	1,215,438	$25.37M	0.0%	-1.5%	1.019%
2/14/2025	Susquehanna International Group LLP	99,213	$2.07M	0.0%	+2.4%	0.083%
2/14/2025	Hsbc Holdings PLC	36,337	$0.76M	0.0%	+64.7%	0.030%
2/14/2025	State of Tennessee Department of Treasury	50,587	$1.06M	0.0%	+4.5%	0.042%
2/14/2025	Tower Research Capital LLC TRC	26,491	$0.55M	0.0%	+242.6%	0.022%
2/14/2025	MetLife Investment Management LLC	68,087	$1.42M	0.0%	+6.9%	0.057%
2/14/2025	Mesirow Institutional Investment Management Inc.	742,295	$15.49M	1.2%	-7.3%	0.622%
2/14/2025	BI Asset Management Fondsmaeglerselskab A S	116,758	$2.44M	0.0%	N/A	0.098%
2/14/2025	Dimensional Fund Advisors LP	3,013,032	$62.88M	0.0%	-0.2%	2.526%
2/14/2025	First Trust Advisors LP	2,233,834	$46.62M	0.0%	-8.0%	1.873%
2/14/2025	Freedom Investment Management Inc.	12,710	$0.27M	0.0%	-20.1%	0.011%
2/14/2025	Altium Capital Management LLC	255,000	$5.32M	1.5%	-33.8%	0.214%
2/13/2025	CANADA LIFE ASSURANCE Co	133,207	$2.78M	0.0%	-2.9%	0.112%
2/13/2025	Canada Pension Plan Investment Board	59,600	$1.24M	0.0%	N/A	0.050%
2/13/2025	Marshall Wace LLP	253,637	$5.29M	0.0%	-70.5%	0.213%
2/13/2025	EAM Investors LLC	134,124	$2.80M	0.4%	-16.8%	0.112%
2/13/2025	Jump Financial LLC	14,074	$0.29M	0.0%	-59.7%	0.012%
2/13/2025	Walleye Capital LLC	14,183	$0.30M	0.0%	-94.3%	0.012%
2/13/2025	XTX Topco Ltd	26,802	$0.56M	0.0%	+38.9%	0.022%
2/13/2025	CreativeOne Wealth LLC	36,694	$0.77M	0.0%	N/A	0.031%
2/13/2025	Barclays PLC	244,423	$5.10M	0.0%	-1.6%	0.205%
2/13/2025	Summit Investment Advisors Inc.	11,696	$0.24M	0.2%	+5.2%	0.010%
2/13/2025	Kennedy Capital Management LLC	1,017,666	$21.24M	0.5%	-2.3%	0.853%
2/13/2025	LSV Asset Management	777,124	$16.22M	0.0%	-18.3%	0.652%
2/13/2025	Capital Fund Management S.A.	123,456	$2.58M	0.0%	-6.9%	0.104%
2/13/2025	Raymond James Financial Inc.	329,980	$6.89M	0.0%	N/A	0.277%
2/13/2025	Martingale Asset Management L P	110,967	$2.32M	0.1%	+27.4%	0.093%
2/13/2025	Renaissance Group LLC	202,760	$4.23M	0.2%	N/A	0.170%
2/13/2025	Renaissance Technologies LLC	2,706,116	$56.48M	0.1%	+7.1%	2.269%
2/13/2025	Legal & General Group Plc	344,623	$7.19M	0.0%	+2.9%	0.289%
2/13/2025	Invesco Ltd.	846,851	$17.67M	0.0%	-9.9%	0.710%
2/13/2025	Bank of Montreal Can	14,879	$0.31M	0.0%	+6.2%	0.012%
2/13/2025	Cerity Partners LLC	26,482	$0.55M	0.0%	-7.8%	0.022%
2/13/2025	Federated Hermes Inc.	174,390	$3.64M	0.0%	+222.1%	0.146%
2/13/2025	Russell Investments Group Ltd.	176,259	$3.68M	0.0%	+1.4%	0.148%
2/13/2025	Envestnet Asset Management Inc.	64,395	$1.34M	0.0%	+162.2%	0.054%
2/13/2025	Aviva PLC	28,160	$0.59M	0.0%	-11.7%	0.024%
2/13/2025	Wells Fargo & Company MN	82,820	$1.73M	0.0%	-46.9%	0.069%
2/12/2025	Cynosure Group LLC	14,048	$0.29M	0.0%	-20.8%	0.012%

Data available starting January 2016

See Full Table

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.

Today's Range

Now: $23.92

$23.75

$24.49

50 Day Range

MA: $22.71

$20.58

$25.74

52 Week Range

Now: $23.92

$14.47

$26.16

Volume

1,282,954 shs

Average Volume

1,115,103 shs

Market Capitalization

$2.91 billion

P/E Ratio

20.27

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of Catalyst Pharmaceuticals?: Catalyst Pharmaceuticals' top insider shareholders include:
Patrick J Mcenany (CEO)
Steve Miller (Insider)
David S Tierney (Director)
Richard J Daly (CEO)
Brian Elsbernd (Insider)
Gary Ingenito (Insider)
Alicia Grande (CFO)
Carmen Jeffrey Del (Insider)
Molly Harper (Director)
Learn More about top insider investors at Catalyst Pharmaceuticals.
Who are the major institutional investors of Catalyst Pharmaceuticals?: Catalyst Pharmaceuticals' top institutional shareholders include:
Vanguard Group Inc. — 7.07%
Deerfield Management Company L.P. Series C — 2.63%
Dimensional Fund Advisors LP — 2.53%
Pacer Advisors Inc. — 2.48%
Renaissance Technologies LLC — 2.27%
Geode Capital Management LLC — 2.23%
Learn More about top institutional investors of Catalyst Pharmaceuticals stock.
Which major investors are selling Catalyst Pharmaceuticals stock?: During the last quarter, CPRX stock was sold by these institutional investors:
Deerfield Management Company L.P. Series C
Marshall Wace LLP
Deutsche Bank AG
Jane Street Group LLC
Voloridge Investment Management LLC
Walleye Capital LLC
Jupiter Asset Management Ltd.
First Trust Advisors LP
Within the previous year, company insiders that have sold Catalyst Pharmaceuticals company stock include:
Patrick J Mcenany (CEO)
Steve Miller (Insider)
David S Tierney (Director)
Richard J Daly (CEO)
Brian Elsbernd (Insider)
Gary Ingenito (Insider)
Alicia Grande (CFO)
Learn More investors selling Catalyst Pharmaceuticals stock.
Which major investors are buying Catalyst Pharmaceuticals stock?: In the last quarter, CPRX stock was acquired by institutional investors including:
Castlekeep Investment Advisors LLC
Bank of America Corp DE
abrdn plc
Arrowstreet Capital Limited Partnership
Vanguard Group Inc.
Raymond James Financial Inc.
Raymond James Financial Inc.
JPMorgan Chase & Co.